1. DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
   Nuno Tiago Tavares et al, 2022, Cancers CrossRef
2. Mechanisms of resistance to chemotherapy in non-small cell lung cancer
   Hye-Young Min et al, 2021, Archives of Pharmacal Research CrossRef
3. miR-26a-5p Suppresses Wnt/β-Catenin Signaling Pathway by Inhibiting DNMT3A-Mediated SFRP1 Methylation and Inhibits Cancer Stem Cell-Like Properties of NSCLC
   Jie Yu et al, 2022, Disease Markers CrossRef
4. Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
   Adnin Ashrafi et al, 2022, Cancers CrossRef
5. Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells
   Somruethai Sumkhemthong et al, 2021, Marine Drugs CrossRef
6. FOXF1 Was Identified as a Novel Biomarker of Infantile Hemangioma by Weighted Coexpression Network Analysis and Differential Gene Expression Analysis
   Yuchao Zhang et al, 2022, Contrast Media & Molecular Imaging CrossRef
7. Cisplatin Resistance: Genetic and Epigenetic Factors Involved
   Yuliannis Lugones et al, 2022, Biomolecules CrossRef